Design. An experimental animal study. Objective. To investigate the relationship between pain-related behavior and the expression of neurotrophic factors in the dorsal root ganglion (DRG) and spinal cord (SC) using a nucleus pulposus (NP) rat model. Summary of Background Data. Neurotrophic factors are released from activated glial cells and are associated with painrelated behavior. Nerve growth factor (NGF) is a neurotrophic factor that is induced by inflammation. Methods. Rats were divided into an NP group (n ¼ 94) and a sham-operated group (n ¼ 46). NP harvested from the tail was applied to the left L5 DRG. Rats in the NP group were then divided into five subgroups: one non-treatment and four treatment groups. In the treatment groups, a dose of anti-NGF antibody or phosphate-buffered saline was administered into the DRG. Behavioral testing was performed to investigate the mechanical withdrawal threshold of the left hind paw for all groups. Immunohistochemical localization of NGF, phosphorylated p38 (p38), and brain-derived neurotrophic factor (BDNF) in the DRGs and SCs was performed, and the numbers of immunoreactive (IR) cells were counted. Results. The withdrawal threshold in the nontreatment NP group was significantly decreased for 35 days, and that of the middleand high-dose treatment rats was significantly higher than the phosphate-buffered saline group values. In the DRG, NGF-IR, p38-IR, and BDNF-IR cells were increased for days 21. In the SC, BDNF-IR, and p38-IR cells were increased from days 7 to 21.
L umbar disc herniation (LDH) is a common disease that induces lower back pain and radiculopathy. Herniated discs induce radiculopathy due to both mechanical compression and chemical inflammation. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Nerve growth factor (NGF) is a target-derived neurotrophin. After a peripheral nerve lesion, a dramatic increase occurs in the amount of NGF protein synthesized in nonneuronal cells (e.g., Schwann cells, macrophages, and smooth muscle cells). 11 The NGF concentration is increased in inflamed tissue, 12, 13 and enhanced retrograde transport of NGF to the dorsal root ganglion (DRG) leads to increased production of brain-derived neurotrophic factor (BDNF) at the gene expression level, mainly in small-and medium-sized neurons. [14] [15] [16] BDNF is transported to the central terminals of primary afferents [17] [18] [19] and may function as a neuromodulator of spinal nociception. [20] [21] [22] [23] [24] [25] BDNF promotes neuronal growth, development, synaptogenesis, differentiation, survival, and neurogenesis. [26] [27] [28] [29] [30] [31] BDNF may play an important neuromodulatory role in the spinal cord (SC) dorsal horn. Expression of P2X4 receptors (P2X4), which are purinoceptors, is upregulated in spinal microglia after nerve injury. 32 Synthesis of BDNF is stimulated by activation of P2X4, and microglia stimulated by P2X4 release BDNF as a crucial factor in signaling to lamina I neurons. 32, 33 The contributions of NGF and BDNF to pain-related behavior are, however, unclear. Here we assessed the relationship between NGF and BDNF expression induced by nucleus pulposus (NP) applied to nerve roots in rats and the pain-related behavior in these rats.
MATERIALS AND METHODS
Animal experiments were carried out following approval by the Animal Care and Use Committee in accordance with our university's Guidelines for Animal Experiments and the Japanese Government Law Concerning the Protection and Control of Animals.
Animals and Anesthesia
A total of 140 adult female Sprague-Dawley rats (Japan SLC, Shizuoka, Japan) weighing 200 to 240 g were used.
The animals were housed in plastic cages at room temperature (218C-248C) on a 12-hour light/dark cycle with free access to food and water. Before surgery, rats were anesthetized by intraperitoneal injection (0.1 mL/100 g body weight) of a combination of 0.3 mL medetomidine hydrochloride (1.0 mg/mL), 0.8 mL midazolam (5.0 mg/mL), and 1.0 ml butorphanol tartrate (5.0 mg/mL).
Experimental Groups
The rats were divided into two surgical groups: the NP application group (NP group, n ¼ 94) and the sham-operated group (sham group, n ¼ 46).
Surgical Procedure
The rat was placed in the prone position, and an incision was made at the midline of the spine at the L4-L6 level. The fascia was incised, and the multifidus muscles were moved laterally to expose the facet joint between the left fifth and sixth lumbar vertebrae. The left L5 DRG and spinal nerve were exposed by a L5/6 facetectomy. For rats in the NP group, NP harvested from the tail was applied to the DRG. The same procedure was performed for sham rats, without NP application to the DRG. In both groups, the spinal muscles were sutured, and the skin was closed using metal clips. [34] [35] [36] Antibody Administration in the Nucleus Pulposus Groups Anti-NGF neutralizing antibody (anti-NGF) (R&D Systems, Minneapolis, MN) was used to treat NP animals. Forty-eight animals in the NP group were divided into four anti-NGF sub-groups (each group, n ¼ 12): low-dose group (0.05 mg/mL), middle-dose group (MD; 0.1 mg/mL), highdose group (HD; 1.0 mg/mL), and control group (0.1 mol/L phosphate-buffered saline [PBS]) ( Table 1 ). These rats were injected with the designated treatment solution (0.1 mL) into the underlayer of the epineurium just distal to the NP, after NP was applied to the DRG.
Behavioral Testing
Sensitivity to non-noxious mechanical stimuli was tested with the von Frey test. All behavioral tests were performed by a researcher unaware of the experimental groupings. Before the experiment, baseline testing was performed to determine the rat's normal responses.
The left hind paw withdrawal response to von Frey filament (monofilament sensory tester, Sakai Med, Tokyo, Japan) stimulation of the plantar surface of the footpad was determined at days 0 (baseline), 7, 14, 21, 28, 35, and 42 (each nontreatment group, n ¼ 10; each treatment group, n ¼ 12). The rat was placed in an acrylic cage with a mesh floor and allowed to acclimate for 30 minutes or until cage exploration and major grooming activities ceased. The lateral plantar surface of the hind paw ipsilateral to the surgical site, which is innervated by the L5 nerve, was stimulated with nine von Frey filaments 
Immunohistochemical Examinations
Immunohistochemical examinations were performed on postoperative days 2, 7, 14, 21, 28, and 35 in the NP and sham groups (each group, n ¼ 6) ( Table 2 ). The rats were anesthetized using isoflurane (Wako Pure Chemical Industries, Osaka, Japan), perfused with fresh 4% paraformaldehyde in PBS, and the left L5 DRGs and L5 segment of the SC were removed. L5 DRGs and SCs were postfixed briefly in 4% paraformaldehyde and embedded in paraffin. Two sections (6 mm thick) were cut from each DRG and each SC and placed individually on separate slides. The following antibodies were used. Glial fibrillary acidic protein (GFAP) was used to label satellite glial cells, NeuN to label neurons, and OX42 to label microglia. NeuN and GFAP antibodies were used on DRG samples. DRG sections were also doublelabeled using anti-NGF, anti-p38, or anti-BDNF antibody. OX42 and NeuN antibodies were used on SC samples. SC sections were also double-labeled using anti-p38 or anti-BDNF antibody. Sections were deparaffinized with xylene and rehydrated with 100% ethanol followed by PBS, and then pretreated with Dako Target Retrieval Solution (Dako North America, Carpinteria, CA) at 958C for 20 minutes to enhance immunoreactivity. Sections were incubated in 2% normal goat serum in PBS/0.3% Triton X-100 or 2% skim milk in PBS for 1 hour at room temperature. Rabbit anti-NGF monoclonal antibody (1:100; Novus Biologicals, Littleton, CO), 36 rabbit anti-BDNF polyclonal antibody (1:500; EMD Millipore Corporation, Billerica, MA), 36 or rabbit anti-p38 monoclonal antibody (1:1000 on DRGs, 1:400 on SCs; Cell Signaling Technology, Beverly, MA) 37 was added, and the samples were incubated overnight at 48C. After washing with PBS, sections were incubated for 1 hour at room temperature with goat anti-rabbit Alexa Fluor 488 (green) fluorescent antibody (1:200; Molecular Probes, Eugene, OR). Next, sections were incubated in 2% normal goat serum in PBS/0.3% Triton X-100 or 2% skim milk in PBS for 1 hour. Samples then were incubated with mouse anti-GFAP monoclonal antibody (1:1000; Millipore), 36 anti-NeuN monoclonal antibody (1:400; Millipore), 35 or anti-OX42 monoclonal antibody (1:100; Bio-Rad Laboratories, Hercules, CA) 38 overnight at 48C. The sections were rinsed in PBS and incubated for 1 hour at room temperature with goat anti-mouse Alexa Fluor 555 (red) (1:200; Molecular Probes). After rinsing, the sections were mounted on microscope slides with Vectashield mounting medium containing DAPI (H-1200, Vector, Burlingame, CA).
Fluorescent staining was analyzed using a fluorescent microscope (BX53, Olympus, Tokyo, Japan) with a digital camera (DP73, Olympus). Two sections of each DRG were used to determine the numbers of NGF-immunoreactive (IR) cells, BDNF-IR cells, and p38-IR cells. The percentage of each type of IR neuron of the total number of neurons was computed for the DRG and averaged. The numbers of BDNF-IR cells and p38-IR cells were counted in an area 150 Â 150 mm in five sections of the ipsilateral SC dorsal horn. The number of each IR cell type in five SC slides was added and averaged.
Statistical Analysis
All measurements are reported as the mean AE standard deviation (SD). Differences in thresholds in the behavior tests among multiple groups were assessed with the Bonferroni post hoc test. Differences in the number/percentage of positive cells between two groups were assessed with the Mann-Whitney U test. P values <0.05 were considered significant.
RESULTS
Behavioral Testing of the Nontreatment groups Figure 1 shows the results of the mechanical withdrawal threshold for the nontreatment group. The mechanical withdrawal threshold in the NP group decreased to its lowest level on day 7 and then gradually increased. Significant differences in the threshold between the NP and sham groups were observed from days 7 to 35 (P < 0.05).
Immunohistochemical Analysis of Nerve Growth Factor, p38, and Brain-Derived Neurotrophic Factor in Dorsal Root Ganglions Satellite cells and neurons were positive for NGF (Figure 2A ). The percentage of NGF-IR neurons in the NP group increased significantly from days 2 to 21 compared to the sham group (P < 0.05) ( Figure 2B ). In the NP group, p38 was expressed in DRG neurons but not satellite cells. The percentage of p38-IR neurons in the NP group increased significantly from day 7 to 21 compared to the sham group (P < 0.05) ( Figure 3A, B) .
In the NP group, BDNF was expressed in DRG neurons but not satellite cells (Figure 4 A) . The percentage of BDNF-IR neurons in the NP group also increased Figure 1 . Behavioral testing of the nontreatment groups. In the NP group, the mechanical withdrawal threshold decreased after surgery. Significant differences between the NP and sham groups were observed from day 7 to 35 (P < 0.05). NP indicates nucleus pulposus.
significantly from day 7 to 21 compared to the sham group (P < 0.05) ( Figure 4B ).
Immunohistochemical Analysis of p38 and BrainDerived Neurotrophic Factor in the Spinal Cord
Microglia and neurons expressed p38 in the SC ( Figure 5A ). In the NP group, the number of p38-IR cells increased significantly from day 2 to 21 compared to the sham group (P < 0.05) ( Figure 5B ). Microglia and neurons expressed BDNF in the SC ( Figure 6A ). The number of BDNF-IR cells in the NP group increased significantly from day 2 to 21 compared to the sham group (P < 0.05) ( Figure 6B ). Figure 7 shows the mechanical withdrawal threshold for the treatment groups. In the MD and HD groups, the mechanical withdrawal thresholds were significantly increased compared to the control group (P < 0.05). The threshold in the HD group was significantly higher on days 7, 14, and 21; the threshold in the MD group was significantly higher on days 7 and 14 compared to the control group. The threshold in the low-dose group was not significantly different from the control values at any times.
Behavioral Testing of the Treatment Groups

DISCUSSION
Local synthesis of inflammatory cytokines such as interleukin-1b and tumor necrosis factor-a occurs in macrophages after peripheral tissue injury or inflammation; these cytokines induce the production of NGF by epithelial cells and fibroblasts. 39 NGF is incorporated into neurons, and then retrogradely transported to the primary afferent neuronal cell bodies in the DRG, in which NGF enhances the expression of proteins, further increasing the excitability of the cell body.
40,41 NGF expression is induced in satellite cells after sciatic nerve transection. 42 These resident endoneurial macrophages in the DRG become more prominent and increase in number after peripheral nerve injury, 43, 44 and resident endoneurial macrophages are activated in DRGs 2 days after NP application. 45 In the present study, NGF expression was increased in neurons and satellite cells of DRGs post-NP application, suggesting that endoneurial macrophages in the DRG were activated, and that inflammatory cytokines that were produced by their activation induced the activation of satellite cells, so that NGF was induced in satellite cells and incorporated into DRG neurons.
NGF produced by inflammatory responses in the dorsal root and DRG tissues may affect BDNF production in the DRG. 46, 47 Phosphorylation of p38 mitogen-activated protein kinase (MAPK) in the ipsilateral DRG is induced in a spinal nerve ligation model. 48, 49 p38 activation in the DRG is initiated by retrograde transport of NGF released from inflamed tissue and contributes to the maintenance of inflammatory heat pain hypersensitivity. 38 Asialoerythropoietin suppresses the elevation of p38 expression in a rat LDH model and contributes to early improvements in pain-related behaviors. 50 p38 expression is also observed in microglia in a disc herniation model, and inhibition of p38 decreases mechanical allodynia in rat LDH models. 51 Therefore, activation of p38 in DRGs and the SC is associated with pain-related behavior. Furthermore, BDNF plays an important neuromodulatory role in the SC dorsal horn. 22 BDNF is anterogradely transported along central processes and is present in the SC in all terminal fields. BDNF released from primary afferent terminals may play a key role in chronic pain states by modulating dorsal horn activity in various ways. 18 Phosphorylated p38 MAPK immunofluorescence in the dorsal horn is seen exclusively in microglia, and the development of tactile allodynia requires activation of p38 MAPK in spinal microglia. 37 Local spinal administration of ATP-stimulated microglia changes the spinal output neurons and stimulates microglial BDNF release as a crucial factor in the signaling to dorsal horn neurons. 52 According to our study, NGF was expressed in DRG neurons and satellite cells beginning 2 days postsurgery, whereas p38 and BDNF were expressed in DRG neurons but not in satellite cells beginning at 7 days. Thus, NGF may induce p38 and BDNF in DRG neurons and may be involved in increased pain-related behavior. NGF expressed in satellite cells was incorporated into DRG neurons. In addition, in the present study, p38 and BDNF expression in the SC was increased beginning on day 2 in the NP group, and mechanical thresholds decreased during the same period. In contrast, p38 and BDNF expression in the DRG was increased beginning on day 7. These results suggest that early p38 and BDNF expression in the SC is not involved in the p38 or BDNF expression in the DRG.
p38 MAPK phosphorylation is the necessary bridge between P2X4 receptor activation and the synthesis and release of BDNF by microglial cells. 53 BDNF signaling appears to contribute to central sensitization and nocifensive behaviors in animal models of chronic pain. 54 In our study, the expression phases of p38 and BDNF in the SC were increased up to day 21. Expression of these molecules was observed during the maintenance phase of pain-related behavior. These results suggest that expression of NGF in DRGs due to application of NP is involved in p38 and BDNF in the SC, and expression of p38 and BDNF may affect the maintenance of pain-related behavior.
The functional link between increased levels of NGF and pain was determined with studies in animals and humans. 55 In the present study, anti-NGF antibody treatment of DRGs in an NP-applied rat model did not reduce the mechanical withdrawal threshold. Our findings indicate that NGF may play an important role in pain-related behavior.
CONCLUSION
We examined the expression of NGF, p38, and BDNF in DRGs and the SC dorsal horn and evaluated their relationship with pain-related behavior. Application of anti-NGF antibody to DRGs improved pain-related behavior in an NP-applied rat model, and thus NGF may play a significant role in, and be a target for agents to treat, neuropathic pain.
Key Points
NGF plays an important role in the neuropathic pain state. NGF induced the expression of p38 and BDNF in DRG, and p38 and BDNF were increased in the SC, possibly affecting the maintenance of painrelated behavior. Anti-NGF antibody treatment of DRGs in a rat NP model did not reduce the mechanical withdrawal threshold. Effect of AnƟ-NGF AnƟbody Figure 7 . Behavioral testing for treatment groups. Mechanical withdrawal thresholds in the MD and HD groups were significantly increased compared with the control group (P < 0.05). The threshold in the HD group was significantly higher on days 7, 14, and 21, and the threshold in the MD group was significantly higher on days 7 and 14 compared to the control group. The threshold in the LD group was not different compared with the control group. HD indicates highdose; LD, low-dose; MD, middle-dose; NGF, nerve growth factor.
